Dual-layer detector spectral CT for predicting p16 status in head and neck squamous cell carcinoma

被引:1
|
作者
Li, Zhijun [1 ,2 ,3 ,4 ]
Ye, Lu [1 ,2 ,3 ,4 ]
Xiao, Jianyu [1 ,2 ,3 ,4 ]
Lu, Xiaomei [5 ]
Ye, Zhaoxiang [1 ,2 ,3 ,4 ]
机构
[1] Tianjin Med Univ, Dept Radiol, Canc Inst & Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc, Natl Clin Res Ctr Canc, Inst & Hosp, Tianjin, Peoples R China
[3] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
[4] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[5] Philips Healthcare, CT Clin Sci CT, Shenyang, Peoples R China
关键词
Head and neck squamous cell carcinoma; Spectral CT; HPV; p16; Quantitative analysis; HUMAN-PAPILLOMAVIRUS; SURVIVAL;
D O I
10.1007/s42058-023-00123-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundHPV-positive head and neck squamous cell carcinoma (HNSCC) differs from HPV-negative HNSCC in clinical features, biological behavior, pathological manifestations, cytogenetics and tend to have better outcome. Immunohistochemical (IHC) p16 staining is highly sensitive for HPV status exam, but has a certain probability of false positives, and the accurate result of p16 expression could be challenging due to the limitation of the biopsy location and quantity. As a non-invasive approach, dual-layer detector spectral CT (DLSCT) provides multi-parameter quantitative analysis, which could help better reflect the changes of tumor characteristics. Hence, this study aimed to evaluate the spectral-derived differences between the p16( +) and p16(-) group of HNSCC so as to explore the application in preoperative diagnosis in differentiating the p16 expression status of HNSCC.Materials and methodsThe spectral data of 35 patients with biopsy confirmed HNSCC were retrospectively analyzed and compared between p16( +) (n = 11) and p16(-) (n = 25) group. All statistical analyses were performed on SPSS v26.0.ResultsEffective atomic number (Zeff), slope value of virtual monoenergetic image (VMI), and normalized iodine density (NID) of p16( +) group were all significantly lower than p16(-) group (8.36 (8.24, 8.42) vs. 8.57 (8.38, 8.85), 2.45 (2.22, 2.64) vs. 3.06 (2.50, 3.82), 0.43 & PLUSMN; 0.09 vs. 0.55 & PLUSMN; 0.14, respectively) (p < 0.05). Besides, NID showed a good ability to discriminate p16(-) HNSCC from p16( +) HNSCC (AUC = 0.788) with a threshold value of 0.495.ConclusionDLSCT could be helpful for the differentiation of p16 expression in HNSCC.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [21] High p16 Expression Predicts a Positive Response to Chemoradiotherapy in Stage IVa/b Head and Neck Squamous Cell Carcinoma
    Chen, Yi-Ju
    Rau, Kun-Ming
    Chien, Chih-Yen
    Fang, Fu-Min
    Huang, Tai-Lin
    Chiu, Tai-Jan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (03) : 649 - 655
  • [22] Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients
    Molimard, Chloe
    L'Huillier, Virginie
    Overs, Alexis
    Soret, Christine
    Algros, Marie-Paule
    Mougin, Christiane
    Guenat, David
    Mauvais, Olivier
    Pretet, Jean-Luc
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (07)
  • [23] IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis
    Riener, Marc-Oliver
    Hoegel, Josef
    Iro, Heinrich
    Hartmann, Arndt
    Agaimy, Abbas
    ONCOLOGY LETTERS, 2017, 14 (02) : 1665 - 1670
  • [24] p16 and p53 can Serve as Prognostic Markers for Head and Neck Cell Carcinoma
    Wang, Yue
    Wang, Fang
    Wang, Shuhan
    Zhang, Lingnan
    Fu, Honghai
    Sun, Legang
    Wang, Wenlong
    Liu, Chunxia
    Ren, Wenhao
    Gao, Ling
    Xing, Guoyi
    Ma, Xiangrui
    INTERNATIONAL DENTAL JOURNAL, 2024, 74 (03) : 543 - 552
  • [25] Predicting Residual Neck Disease in Patients With Oropharyngeal Squamous Cell Carcinoma Treated With Radiation Therapy Utility of p16 Status
    Shonka, David C., Jr.
    Shoushtari, Asal N.
    Thomas, Christopher Y.
    Moskaluk, Christopher
    Read, Paul W.
    Reibel, James F.
    Levine, Paul A.
    Jameson, Mark J.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (11) : 1126 - 1132
  • [26] p16 immunocytochemistry on aspirate smears of neck masses: Another option for determining the HPV status in metastatic head and neck squamous cell carcinoma
    Griffith, Christopher C.
    CANCER CYTOPATHOLOGY, 2019, 127 (07) : 423 - 425
  • [27] Dual-layer spectral-detector CT for predicting microsatellite instability status and prognosis in locally advanced gastric cancer
    Zhu, Yongjian
    Wang, Peng
    Wang, Bingzhi
    Jiang, Zhichao
    Li, Ying
    Jiang, Jun
    Zhong, Yuxin
    Xue, Liyan
    Jiang, Liming
    INSIGHTS INTO IMAGING, 2023, 14 (01)
  • [28] Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma
    Ryu, Hyang Joo
    Kim, Eun Kyung
    Heo, Su Jin
    Cho, Byoung Chul
    Kim, Hye Ryun
    Yoon, Sun Och
    APMIS, 2017, 125 (11) : 974 - 984
  • [29] PROGNOSTIC SIGNIFICANCE OF P16 IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK TREATED WITH CONCURRENT CISPLATIN AND RADIOTHERAPY
    Lau, Harold Y.
    Brar, Sony
    Klimowicz, Alexander C.
    Petrillo, Stephanie K.
    Hao, Desiree
    Brockton, Nigel T.
    Kong, Christina S.
    Lees-Miller, Susan P.
    Magliocco, Anthony M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (02): : 251 - 256
  • [30] Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma
    Lundberg, Marie
    Leivo, Ilmo
    Saarilahti, Kauko
    Makitie, Antti A.
    Mattila, Petri S.
    ACTA OTO-LARYNGOLOGICA, 2012, 132 (09) : 1006 - 1012